Brief: Carerx Posts Quarterly Loss Per Share Of $0.11
Nov 9 (Reuters) - CareRx Corp CRRX.TO :
* CARERX REPORTS 56% YEAR-OVER-YEAR GROWTH IN REVENUE AND
79%
YEAR-OVER-YEAR GROWTH IN ADJUSTED EBITDA FOR THE THIRD QUARTER
OF 2021
* QTRLY REVENUE FROM CONTINUING OPERATIONS INCREASED 56% TO
$71.3
MILLION
* QTRLY LOSS PER SHARE $0.11
* Q3 EARNINGS PER SHARE VIEW C$-0.11, REVENUE VIEW C$64.6
MILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nCNWSC24ca
Further company coverage: CRRX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q2 revenue rises, slightly misses estimates
Canada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates